Labor characteristics of uncomplicated prolonged pregnancies after induction with intracervical prostaglandin E2 gel versus intravenous oxytocin. 1992

I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
First Department of Obstetrics and Gynecology, University of Athens, Alexandra Maternity Hospital, Greece.

Labor characteristics after intracervical application of 0.5 mg prostaglandin (PG) E2 gel (n = 83) versus intravenous administration of oxytocin (n = 82) for labor induction were investigated in uncomplicated prolonged pregnancies with unripe cervix. The induction to delivery time as well as the total oxytocin dose were significantly reduced in the PGE2 group (p < 0.001). Cesarean sections, instrumental deliveries and fetal distress had the same frequency, but the failures of trial were significantly higher in the oxytocin group than in the PGE2 group (20.7 vs. 6%, p < 0.01). Twenty-four percent of women needed a second PGE2 dose, and almost half of the women in the PGE2 group experienced 'spontaneous' labor. More neonates in the oxytocin group had 5-min Apgar scores < 7 (p < 0.05). Intracervical PGE2 gel application is superior to intravenous oxytocin in terms of shortening the induction-delivery interval and increasing the frequency of successful vaginal delivery. In addition, it is safe for mother and fetus.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007751 Labor, Induced Artificially induced UTERINE CONTRACTION. Induced Labor,Induction of Labor,Labor Induced,Labor Induction,Induced, Labor,Induction, Labor,Inductions, Labor,Labor Inductions
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010298 Parity The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome. Multiparity,Nulliparity,Primiparity,Parity Progression Ratio,Parity Progression Ratios,Ratio, Parity Progression,Ratios, Parity Progression
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011273 Pregnancy, Prolonged A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more. Prolonged Pregnancy,Pregnancies, Prolonged,Prolonged Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000282 Administration, Intravaginal The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Vaginal,Drug Administration, Vaginal,Instillation, Vaginal,Intravaginal Administration,Vaginal Drug Administration,Vaginal Administration,Administration, Vaginal Drug,Administrations, Intravaginal,Administrations, Vaginal,Administrations, Vaginal Drug,Drug Administrations, Vaginal,Instillations, Vaginal,Intravaginal Administrations,Vaginal Administrations,Vaginal Drug Administrations,Vaginal Instillation,Vaginal Instillations

Related Publications

I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
October 1995, American journal of obstetrics and gynecology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
November 1988, Obstetrics and gynecology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
November 1998, American journal of obstetrics and gynecology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
November 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
November 1991, European journal of obstetrics, gynecology, and reproductive biology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
July 1998, Medical journal, Armed Forces India,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
October 1990, Obstetrics and gynecology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
May 1980, European journal of obstetrics, gynecology, and reproductive biology,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
January 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
I Papageorgiou, and C Tsionou, and D Minaretzis, and S Michalas, and D Aravantinos
May 1992, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Copied contents to your clipboard!